Bionano Genomics (BNGO) Debt/EBITDA US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
Debt/EBITDA -0.10 0.60 3.25 0.84 0.11   -0.11  
Changes by years, y/y, % -129% -680% +445% -74% -88%     -21.6%

Bionano Genomics. Debt/EBITDA

Bionano Genomics. Debt/EBITDA, changes, %

Bionano Genomics (BNGO) Debt/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Debt/EBITDA 0.24 0.06 0.05 -0.05 -0.11   -0.11
Changes by years, y/y, % -85% -92% -93% -110% -146%    
Changes by quarters, q/q, % -49% -74% -26% -199% +144%    

Bionano Genomics. Debt/EBITDA

Bionano Genomics. Debt/EBITDA, changes, y/y, %

Bionano Genomics. Debt/EBITDA, changes, q/q, %